Olson BM[au] - Search Results

Year	Number of Results
1964	1
2002	1
2003	5
2004	1
2005	1
2006	4
2007	5
2008	1
2009	3
2010	2
2011	4
2012	5
2013	5
2014	1
2015	1
2016	2
2017	4
2020	3
2021	3

1

Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.

Patnaik A, Swanson KD, Csizmadia E, Solanki A, Landon-Brace N, Gehring MP, Helenius K, Olson BM, Pyzer AR, Wang LC, Elemento O, Novak J, Thornley TB, Asara JM, Montaser L, Timmons JJ, Morgan TM, Wang Y, Levantini E, Clohessy JG, Kelly K, Pandolfi PP, Rosenblatt JM, Avigan DE, Ye H, Karp JM, Signoretti S, Balk SP, Cantley LC. Patnaik A, et al. Among authors: olson bm. Cancer Discov. 2017 Jul;7(7):750-765. doi: 10.1158/2159-8290.CD-16-0778. Epub 2017 Mar 8. Cancer Discov. 2017. PMID: 28274958 Free PMC article.

2

Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer.

Zhang Y, Ware MB, Zaidi MY, Ruggieri AN, Olson BM, Komar H, Farren MR, Nagaraju GP, Zhang C, Chen Z, Sarmiento JM, Ahmed R, Maithel SK, El-Rayes BF, Lesinski GB. Zhang Y, et al. Among authors: olson bm. Mol Cancer Ther. 2021 Jan;20(1):150-160. doi: 10.1158/1535-7163.MCT-19-0911. Epub 2020 Oct 9. Mol Cancer Ther. 2021. PMID: 33037138

3

Infectious Tolerance as Seen With 2020 Vision: The Role of IL-35 and Extracellular Vesicles.

Sullivan JA, AlAdra DP, Olson BM, McNeel DG, Burlingham WJ. Sullivan JA, et al. Among authors: olson bm. Front Immunol. 2020 Aug 26;11:1867. doi: 10.3389/fimmu.2020.01867. eCollection 2020. Front Immunol. 2020. PMID: 32983104 Free PMC article. Review.

4

Sipuleucel-T: immunotherapy for advanced prostate cancer.

Olson BM, McNeel DG. Olson BM, et al. Open Access J Urol. 2011 May 3;3:49-60. doi: 10.2147/OAJU.S13069. Open Access J Urol. 2011. PMID: 24198636 Free PMC article. Review.

5

Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer.

Kyriakopoulos CE, Eickhoff JC, Ferrari AC, Schweizer MT, Wargowski E, Olson BM, McNeel DG. Kyriakopoulos CE, et al. Among authors: olson bm. Clin Cancer Res. 2020 Oct 1;26(19):5162-5171. doi: 10.1158/1078-0432.CCR-20-0945. Epub 2020 Jun 8. Clin Cancer Res. 2020. PMID: 32513836 Free PMC article.

6

Preclinical and clinical development of DNA vaccines for prostate cancer.

Colluru VT, Johnson LE, Olson BM, McNeel DG. Colluru VT, et al. Among authors: olson bm. Urol Oncol. 2016 Apr;34(4):193-204. doi: 10.1016/j.urolonc.2013.09.014. Epub 2013 Dec 12. Urol Oncol. 2016. PMID: 24332642 Free PMC article. Review.

7

Update on the National Vaccine Injury Compensation Program.

Edlich RF, Olson DM, Olson BM, Greene JA, Gubler KD, Winters KL, Kelley AR, Britt LD, Long WB 3rd. Edlich RF, et al. Among authors: olson bm. J Emerg Med. 2007 Aug;33(2):199-211. doi: 10.1016/j.jemermed.2007.01.001. Epub 2007 Jun 18. J Emerg Med. 2007. PMID: 17692778 Review.

8

Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.

Olson BM, Sullivan JA, Burlingham WJ. Olson BM, et al. Front Immunol. 2013 Oct 18;4:315. doi: 10.3389/fimmu.2013.00315. Front Immunol. 2013. PMID: 24151492 Free PMC article. Review.

9

DNA Vaccines for Prostate Cancer.

McNeel DG, Becker JT, Johnson LE, Olson BM. McNeel DG, et al. Among authors: olson bm. Curr Cancer Ther Rev. 2012 Nov 1;8(4):254-263. doi: 10.2174/157339412804143113. Curr Cancer Ther Rev. 2012. PMID: 24587772 Free PMC article.

10

Approaches to pharmacy benefit management and the impact of consumer cost sharing.

Olson BM. Olson BM. Clin Ther. 2003 Jan;25(1):250-72. doi: 10.1016/s0149-2918(03)90035-x. Clin Ther. 2003. PMID: 12637125 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results